detekdi dini ca. pd dr. indra-onko
TRANSCRIPT
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 1/45
BREAST CANCEREpidemiologi
Penyebab dan Faktor Resiko
Gejala dan Tanda
Stadium
Tindak Lanjut
Training 5 Hari Dokter-Bidan-Kader
Female Cancer Programme FKUI-RSCM/
YKI DKI dan Dinas Kesehatan DKI Jakarta
Indra Hidayah Siregar/
Ahmad Kurnia
Divisi Bedah Onkologi FKUI/RSCM Jakarta
Departemen Bedah FKUI/RSCM Jakarta
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 2/45
Ca mamae sin std IIIb
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 3/45
Ca mamae dex s td IIIb
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 4/45
Post m astectomy a/I Ca mamae dex std
IIIb- b ilateral std IV
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 5/45
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 6/45
In t roduct ion
• Most common female cancer
• Accounts for 32% of all female cancer
• 211,300 new cases yearly and rising
• 40,000 deaths yearly
US data
Indonesia ?
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 7/45
• Profil Kesehatan Indonesia 2008 :
– Urutan pertama (2004-2007)
– 8277 kasus (16,85%)
– Insidens di Indonesia : 36,2 per 100.000 pr
dengan angka kematian : 18,6 per 100.000
pr. (20.052 kasus). Data oleh GlobalBurden of Cancer, 2008.
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 8/45
• RSCM :
– Penelitian terhadap 300 pasien bedah,
(1989-1992) terbanyak : kanker payudaralanjut lokal (66%).
– 1998-2002 : 27,5%, tetapi stadium IV
meningkat (47,4%).
– US : KPLL < 5%
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 9/45
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 10/45
10 KANKER TERBANYAK DIINDONESIA
Number ICD Location Relative Frequency
1. 2. 3. 4. 5. 6. 7.
8. 9. 10.
180 174 173 147
183 196
154 171 193
Cervix Women's breast
Skin Nasopharynx
Unknown Ovaries
Lymphoid nodes
Rectum Soft tissue
Thyroid
18,41 %11,57 %8,24 %6,15 %5,16 %4,94 %4,91 %
4,42 %3,50 %3,38 %
Source: Bulletin of Pathology Based Cancer Registry, BRK-IAP, No. 4, 1989.
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 11/45
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 12/45
BREAST CANCERAge-speci fic incidence (per 100,000)
United
States
England
and Wales
Italy
France
Japan
Incidence rates
20 25 30 35 40 45 50 55 60 65 70 75 80 85+
24 29 34 39 44 49 54 59 64 69 74 79 84
420400
300
200
100
0
Age
Adapted from New Horizons in Cancer Management, SRI International, 1990.
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 13/45
BREAST CANCERRisk factors
Female
History of breast cancer
Family history of breast cancer, especially in
first-degree relatives : 1,8 x
Benign breast “cancer”/ atypical hyperplasia : 5 x
Early menarche : 1,7-3,4 x, late menopause : 1,5 x
Late first pregnancy/no pregnancy : 1,5-4 x
Exogenous estrogens
Radiation ( < 16 yo:100x, 20-29yo:6x, >30yo : -)
? Diet, alcohol
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 14/45
BREAST CANCERIncidence of major histo logic types
Percent of all Infiltrating Carcinomas
78%
9%4% 3% 5%
1%
Ductal Lobular Medullary Colloid Comedo Papillary
Adapted from McDivitt R et al, 1967.
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 15/45
Range ofDuctal Carcinoma in situ
15 I l l u s t r a t i o n ©
M a r y K .
B r y s o n
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 16/45
Detection
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 17/45
American Cancer Soc iety
• Skrining kanker payudara sedini
mungkin :
– Pr > 20 thn : sadari tiap bulan
– Pr > 20-40 thn : memeriksakan diri ke
dokter tiap 3 tahun
– Pr > 40 thn : memeriksakan diri ke doktertiap tahun
– Pr 35-40 thn : base line mammografi
– Pr > 50 thn : mammografi tiap tahun.
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 18/45
Waktu mamografi
Sebaiknya dikerjakan pada :
• Wanita usia diatas 35/40 tahun sebagaibaseline
• Wanita dengan faktor risiko tinggi
• 7-10 hari masa haid
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 19/45
Palpable mass
Thickening
Pain
Mass or pain
in the axilla
Nipple discharge
Nipple retraction
Edema or erythema
of the skin
BREAST CANCER/LOCAL MANIFESTATIONS
Signs and symptoms at presentat ion
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 20/45
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 21/45
Nipp le retracted
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 22/45
Nipp le dischrge
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 23/45
Peau d’orange
H i /
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 24/45
Hyperemis /
mast i tis carc inomatous
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 25/45
T 4
Ulkus
Peau d’Orange
Nipple retracted
Mass
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 26/45
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 27/45
Lymph nodes
Skin
Liver
Kidney
Brain
Pulmonary
Bone
BREAST CANCER/DISTANT MANIFESTATIONS
Signs and symptom s at presentat ion
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 28/45
Distan t Metastase
• Paru batuk, sesak,foto thorax
• Hati hepatomegali, USG hepar
• Tulang nyeri ketok,foto polos, bone scan
• Otak nyeri kepala hebat, scan
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 29/45
What Mammograms Show
Two of the most important mammographicindicators of breat cancers
– Masses
– Microcalcifications: Tiny flecks of calcium – likegrains of salt – in the soft tissue of the breastthat can sometimes indicate an early cancer.
29
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 30/45
Detection of Malignant Masses
Malignant masses have a more spiculated
appearance
30
malignant
benign
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 31/45
Mammogram – Difficult Case
31
• Heterogeneously dense breast
• Cancer can be difficult todetect with this type of
breast tissue
• The fibroglandular tissue(white areas) may hide thetumor
• The breasts of youngerwomen contain more glandsand ligaments resulting indense breast tissue
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 32/45
Mammogram – Easier Case
32
• With age, breast tissue
becomes fattier and hasfewer glands
• Cancer is relatively easyto detect in this type ofbreast tissue
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 33/45
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 34/45
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 35/45
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 36/45
BREAST CANCER
TNM stage grouping
Stage 0 Tis. N0 M0
Stage I T1 N0 M0
Stage IIA T0, T1 N1 M0
T2 N0 M0Stage IIB T2 N1 M0
T3 N0 M0
Stage IIIA T0, T1, T2 N2 M0
T3 N1, N2 M0Stage IIIB Any T N3 M0
T4 Any N M0
Stage IV Any T Any N M1
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 37/45
BREAST CANCERSurvival by s tage
Stage 0
Stage I
Stage IIA
Stage IIB
Stage IIIA
Stage IIIB
Stage IV
Percent surviving
100
80
60
40
20
0
1 2 3 4 5 6
Years after diagnosis
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 38/45
BREAST CANCER SCREENING PATH
Fine-needle aspiration
biopsy
Breast self-examination
Palpable
mass
(not cyst)
Diagnostic imaging
- mammogram
- ultrasound
- compression magnification filmNormal
Physical examination(yearly)
Screening mammogram(guidelines)
Suspicious Equivocal
Equivocal or
suspicious
Probably
benignCyst
Short-term
follow-upAspiration
Normal
– +
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 39/45
BREAST CANCER DIAGNOSIS PATH
Evaluation
for
biopsy
Cyst
aspiration
Fine-needle aspiration
biopsy
Needle
localization
Palpable
mass
Ductal
carcinoma
in situ
Invasive
cancer
Lobular
carcinoma
in situ
BenignInsufficientevaluation,rebiopsy
If persistent,
short-term
follow-up
with surgeon
Continued
appropriate
screening
Cyst Normal
Nonpalpable
mass
Treatment Path
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 40/45
BREAST CANCERTherapeut ic opt ions
Surgery
Radiotherapy
Chemotherapy
Hormonal therapy
Immunotherapy
New therapies
Supportive care
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 41/45
BREAST CANCERSurgical opt ions I
Local excision
mass
mass
Wide excision
…... Quadrantectomy
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 42/45
BREAST CANCERSurg ical op t ions II
Modified radical mastectomy Radical mastectomy
Incision
Excised area
mass mass
nodes
nodes
Excised area
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 43/45
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 44/45
8/10/2019 Detekdi Dini CA. Pd Dr. Indra-Onko
http://slidepdf.com/reader/full/detekdi-dini-ca-pd-dr-indra-onko 45/45